2024-21904. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Device Recall Authority  

  • Table 1—Estimated Annual Reporting Burden 1

    Collection activity—21 CFR section Number of respondents Number of responses per respondent Total annual responses Average burden per response Total hours
    Submission of information to FDA about device distribution and remedial actions to be taken, as specified in the order—810.10(d) 2 1 2 8 16
    Submission of a written request for regulatory hearing—810.11(a) 1 1 1 8 8
    Submission of a written request to FDA asking that the order be modified or vacated—810.12(a-b) 1 1 1 8 8
    Submission of a strategy for compliance with cease distribution and notification or mandatory recall order—810.14 2 1 2 16 32
    Submission of periodic status reports to FDA to enable the Agency to assess progress in compliance with the order—810.16(a-b) 2 12 24 40 960
    Submission of a written request to FDA to certify compliance with and terminate the order—810.17(a) 2 1 2 8 16
    Total Hours 1,040
    1  There are no capital costs or operating and maintenance costs associated with this collection of information.

    Table 2—Estimated Annual Recordkeeping Burden 1

    Collection activity—21 CFR section Number of recordkeepers Number of records per recordkeeper Total annual records Average burden per recordkeeping Total hours
    Documentation of communications to appropriate person(s)—810.15(b) 2 1 2 8 16
    1  There are no capital costs or operating and maintenance costs associated with this collection of information.

    Table 3—Estimated Annual Third-Party Disclosure Burden 1

    Collection activity—21 CFR section Number of respondents Number of disclosures per respondent Total annual responses Average burden per disclosure Total hours
    Communications to appropriate person(s) concerning a cease distribution and notification or mandatory recall order—810.15(a)-(c) 2 1 2 12 24
    Follow up communications to appropriate person(s) who fail to respond to the initial communication—810.15(d) 2 1 2 4 8
    ( print page 78315)
    Notifications provided by recipients of communications to appropriate consignees—810.15(e) 10 1 10 1 10
    Total 42
    1  There are no capital costs or operating and maintenance costs associated with this collection of information.

Document Information

Published:
09/25/2024
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2024-21904
Dates:
Submit written comments (including recommendations) on the collection of information by October 25, 2024.
Pages:
78313-78315 (3 pages)
Docket Numbers:
Docket No. FDA-2024-N-2381
PDF File:
2024-21904.pdf